簡介

本頁面提供了有關 Sarah Romano 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Sarah Romano已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:ENTO / Entero Therapeutics, Inc. Chief Financial Officer 17,287
US:KPRX / Kiora Pharmaceuticals, Inc. Chief Financial Officer 22,746
如何解讀這些圖表

以下圖表顯示了在Sarah Romano進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Sarah Romano 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2025-01-08 2025-01-06 4 ENTO Entero Therapeutics, Inc.
Common Stock
S - Sale -727 17,287 -4.04 0.64 -465 11,064
2024-10-10 2024-10-09 4 ENTO Entero Therapeutics, Inc.
Common Stock
S - Sale -476 18,014 -2.57 0.45 -212 8,034
2024-07-03 2024-07-02 4 ENTO Entero Therapeutics, Inc.
Common Stock
S - Sale -621 18,490 -3.25 1.07 -664 19,784
2024-04-03 2024-04-01 4 FWBI First Wave BioPharma, Inc.
Common Stock
S - Sale -75 19,111 -0.39 4.23 -317 80,828
2024-03-19 2024-03-15 4 FWBI First Wave BioPharma, Inc.
Common Stock
S - Sale -1,120 19,186 -5.52 4.96 -5,555 95,163
2024-01-17 2024-01-12 4 FWBI First Wave BioPharma, Inc.
Common Stock
S - Sale -98 20,306 -0.48 4.20 -412 85,285
2024-01-03 2024-01-02 4 FWBI First Wave BioPharma, Inc.
Common Stock
A - Award 7,000 20,404 52.22
2024-01-03 2023-12-29 4 FWBI First Wave BioPharma, Inc.
Common Stock
A - Award 12,614 13,404 1,596.71
2023-10-06 2023-10-04 4 FWBI First Wave BioPharma, Inc.
Common Stock
S - Sale -1,676 15,800 -9.59 0.29 -486 4,582
2023-07-05 2023-07-03 4 FWBI First Wave BioPharma, Inc.
Common Stock
S - Sale -1,977 17,476 -10.16 1.54 -3,045 26,913
2023-04-05 2023-04-03 4 FWBI First Wave BioPharma, Inc.
Common Stock
S - Sale -1,975 19,453 -9.22 2.50 -4,938 48,632
2023-01-05 2023-01-03 4 FWBI First Wave BioPharma, Inc.
Common Stock
A - Award 150,000 150,000
2022-03-02 2022-03-01 4 FWBI First Wave BioPharma, Inc.
Stock option (right to buy)
A - Award 150,000 150,000
2022-02-11 2022-02-10 4 KPRX KIORA PHARMACEUTICALS INC
Common Stock
F - Taxes -108 22,746 -0.47 0.69 -75 15,695
2022-02-03 2022-02-01 4 KPRX KIORA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 50,000 50,000
2022-01-06 2022-01-05 4 KPRX KIORA PHARMACEUTICALS INC
Common Stock
F - Taxes -114 22,854 -0.50 1.08 -123 24,682
2021-12-08 2021-12-07 4 KPRX KIORA PHARMACEUTICALS INC
Common Stock
F - Taxes -91 22,968 -0.39 1.30 -118 29,858
2021-11-03 2021-11-02 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -83 23,059 -0.36 1.98 -164 45,657
2021-10-05 2021-10-04 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -83 23,142 -0.36 2.01 -167 46,515
2021-09-03 2021-09-02 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -84 23,225 -0.36 1.81 -152 42,037
2021-08-04 2021-08-03 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -87 23,309 -0.37 2.40 -209 55,942
2021-07-06 2021-07-02 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -180 23,396 -0.76 3.70 -666 86,565
2021-06-07 2021-06-04 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -180 23,576 -0.76 4.19 -754 98,783
2021-05-05 2021-05-04 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -177 23,756 -0.74 4.13 -731 98,112
2021-04-09 2021-04-08 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -180 23,933 -0.75 4.94 -889 118,229
2021-03-05 2021-03-03 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -218 24,113 -0.90 5.46 -1,190 131,657
2021-02-03 2021-02-02 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -1,282 24,331 -5.01 6.34 -8,128 154,259
2021-02-03 2021-02-01 4 EYEG EYEGATE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 30,000 30,000
2021-01-05 2021-01-04 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -115 25,613 -0.45 4.85 -558 124,223
2020-12-08 2020-12-07 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -91 25,728 -0.35 3.76 -342 96,737
2020-11-03 2020-11-02 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -97 25,819 -0.37 3.51 -340 90,625
2020-10-05 2020-10-02 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -98 25,916 -0.38 3.88 -380 100,554
2020-09-03 2020-09-02 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -97 26,014 -0.37 3.94 -382 102,495
2020-08-05 2020-08-04 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -95 26,111 -0.36 4.11 -390 107,316
2020-07-06 2020-07-02 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -97 26,206 -0.37 4.82 -468 126,313
2020-06-04 2020-06-03 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -94 26,303 -0.36 5.11 -480 134,408
2020-05-06 2020-05-05 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -93 26,397 -0.35 5.10 -474 134,625
2020-04-03 2020-04-02 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -122 26,490 -0.46 4.97 -606 131,655
2020-03-10 2020-03-09 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -130 26,612 -0.49 5.01 -651 133,326
2020-02-19 2020-02-14 4 EYEG EYEGATE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 10,000 10,000
2020-02-19 2020-02-14 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
A - Award 10,000 26,742 59.73
2020-02-05 2020-02-04 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -109 16,742 -0.65 6.00 -654 100,452
2020-01-06 2020-01-03 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -119 16,851 -0.70 9.52 -1,133 160,422
2019-12-20 2019-12-18 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -101 16,970 -0.59 7.46 -753 126,596
2019-11-07 2019-11-05 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -108 17,071 -0.63 3.85 -416 65,723
2019-10-11 2019-10-09 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -185 17,179 -1.07 3.10 -574 53,255
2019-08-07 2019-08-06 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
F - Taxes -1,649 260,464 -0.63 0.21 -346 54,697
2019-07-15 2019-07-15 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
S - Sale -6,584 262,113 -2.45 0.23 -1,534 61,072
2019-07-15 2019-07-12 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
S - Sale -6,583 268,697 -2.39 0.24 -1,551 63,305
2019-07-15 2019-07-11 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
S - Sale -6,583 275,280 -2.34 0.24 -1,584 66,232
2019-02-05 2019-02-01 4 EYEG EYEGATE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 50,000 50,000
2018-07-12 2018-07-10 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
A - Award 175,000 281,863 163.76
2018-04-18 2018-04-17 4 EYEG EYEGATE PHARMACEUTICALS INC
Warrants (right to buy)
P - Purchase 62,500 62,500
2018-04-18 2018-04-17 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
P - Purchase 62,500 106,863 140.88
2018-03-01 2018-02-28 4 EYEG EYEGATE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 25,000 25,000
2018-01-03 2017-12-29 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
J - Other 11,863 44,363 36.50 1.01 11,982 44,807
2017-08-17 2017-08-15 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
P - Purchase 10,000 32,500 44.44 1.00 10,000 32,500
2017-06-22 2017-06-21 4 EYEG EYEGATE PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 40,000 40,000
2017-06-14 2017-06-14 4 EYEG EYEGATE PHARMACEUTICALS INC
Warrants (right to buy)
P - Purchase 20,000 20,000
2017-06-14 2017-06-14 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
P - Purchase 20,000 22,500 800.00
2017-02-08 2017-02-06 4 EYEG EYEGATE PHARMACEUTICALS INC
Common Stock
A - Award 2,500 2,500
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)